Janssen Diabetes Drugs Linked To Amputations, FDA Says
Patients in a clinical trial studying Janssen Pharmaceuticals' diabetes drugs Invokana and Invokamet were roughly twice as likely to undergo amputations as patients taking a placebo, the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article